Diffuse mesangial cell proliferation in focal sclerosing glomerulonephritis

Area of Science:

• Nephrology
• Pathology
• Morphometry

Background:

• Focal glomerulosclerosis (FGS) is a kidney disease characterized by scarring.
• A hypercellular variant of FGS exhibits diffuse mesangial hypercellularity alongside focal sclerosis.
• Distinguishing this hypercellular form from other glomerular diseases is crucial for accurate diagnosis and management.

Purpose of the Study:

• To compare the morphometrical and clinical features of hypercellular FGS with non-hypercellular FGS, mild mesangioproliferative glomerulonephritis (GN), and normal kidneys.
• To determine if the hypercellular form of FGS represents a distinct clinicopathological entity.

Main Methods:

• Morphometrical analysis of kidney biopsies from 34 patients with hypercellular FGS.
• Comparison of mesangial volume and cell count between hypercellular FGS, non-hypercellular FGS, mild mesangioproliferative GN, and controls.
• Clinical data assessment including nephrotic syndrome, hematuria, hypertension, and renal insufficiency.

Main Results:

• Hypercellular FGS showed statistically significant increases in relative mesangial volume and mesangial cell count compared to non-hypercellular FGS and controls.
• Non-hypercellular FGS also had higher mesangial matrix and cells than controls.
• Hypercellular FGS predominantly affected males and older patients, consistently presenting with nephrotic syndrome, and demonstrated poorer therapeutic response and prognosis.

Conclusions:

• The hypercellular form of focal glomerulosclerosis is morphometrically distinct due to increased mesangial volume and cellularity.
• This variant presents with specific clinical characteristics, notably nephrotic syndrome.
• The hypercellular form of FGS should be recognized as a separate entity with significant implications for prognosis and treatment.